(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRG1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:731515 6480464 epigallocatechin gallate results in decreased expression of NRG1 mRNA CTD PMID:20346928 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:731515 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NRG1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:735609 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NRG1 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:735609 6480464 1, 2-Dimethylhydrazine results in decreased expression of NRG1 mRNA CTD PMID:22206623 1-benzylpiperazine increases expression EXP 6480464 N-benzylpiperazine results in increased expression of NRG1 mRNA CTD PMID:26821219 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of NRG1 mRNA CTD PMID:25380136 , PMID:30723492 1-nitropyrene increases expression ISO RGD:731515 6480464 1-nitropyrene results in increased expression of NRG1 mRNA CTD PMID:19041380 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of NRG1 mRNA CTD PMID:20068009 17beta-estradiol multiple interactions ISO RGD:731515 6480464 [NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein more ... CTD PMID:26502914 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:735609 6480464 2 more ... CTD PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:731515 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:731515 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735609 6480464 2 more ... CTD PMID:21851831 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735609 6480464 Tetrachlorodibenzodioxin results in increased expression of NRG1 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735609 6480464 Tetrachlorodibenzodioxin affects the expression of NRG1 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731515 6480464 Tetrachlorodibenzodioxin results in decreased expression of NRG1 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NRG1 mRNA CTD PMID:19692669 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NRG1 mRNA CTD PMID:22298810 , PMID:32109520 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of NRG1 mRNA CTD PMID:21346803 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of NRG1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of NRG1 mRNA CTD PMID:21346803 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of NRG1 mRNA CTD PMID:14600272 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 more ... 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:735609 6480464 tetrabromobisphenol A results in increased expression of NRG1 mRNA CTD PMID:25172293 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:731515 6480464 bisindolylmaleimide I inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK1 protein], bisindolylmaleimide I inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK3 protein] CTD PMID:15231676 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of NRG1 mRNA CTD PMID:35063618 4,4'-sulfonyldiphenol decreases expression ISO RGD:731515 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of NRG1 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NRG1 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases methylation ISO RGD:731515 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of NRG1 gene CTD PMID:31601247 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NRG1 mRNA CTD PMID:14600272 more ... 5-fluorouracil affects response to substance ISO RGD:731515 6480464 NRG1 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NRG1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NRG1 mRNA CTD PMID:25825206 , PMID:30047161 AACOCF3 multiple interactions ISO RGD:731515 6480464 arachidonyltrifluoromethane inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK1 protein], arachidonyltrifluoromethane inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK3 protein] CTD PMID:15231676 acetamide increases expression EXP 6480464 acetamide results in increased expression of NRG1 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:731515 6480464 Acrylamide results in decreased expression of NRG1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NRG1 mRNA CTD PMID:14600272 more ... aflatoxin B1 increases methylation ISO RGD:731515 6480464 Aflatoxin B1 results in increased methylation of NRG1 gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:731515 6480464 aflatoxin B2 results in increased methylation of NRG1 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions EXP 6480464 [NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose more ... CTD PMID:14711829 aldehydo-D-glucose increases transport EXP 6480464 NRG1 protein results in increased transport of Glucose CTD PMID:14711829 all-trans-retinoic acid decreases expression ISO RGD:731515 6480464 Tretinoin results in decreased expression of NRG1 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:731515 6480464 Tretinoin results in increased expression of NRG1 mRNA CTD PMID:23724009 aluminium atom multiple interactions ISO RGD:731515 6480464 [aluminum chlorhydrate results in increased abundance of Aluminum] inhibits the reaction [NRG1 protein results in increased phosphorylation of ESR1 protein] CTD PMID:31945389 aluminium(0) multiple interactions ISO RGD:731515 6480464 [aluminum chlorhydrate results in increased abundance of Aluminum] inhibits the reaction [NRG1 protein results in increased phosphorylation of ESR1 protein] CTD PMID:31945389 amiodarone increases expression ISO RGD:731515 6480464 Amiodarone results in increased expression of NRG1 mRNA CTD PMID:36586010 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of NRG1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NRG1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of NRG1 mRNA CTD PMID:30779732 androgen antagonist multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA CTD PMID:25607892 antimycin A decreases expression ISO RGD:731515 6480464 Antimycin A results in decreased expression of NRG1 mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO RGD:731515 6480464 aristolochic acid I results in decreased expression of NRG1 mRNA, aristolochic acid I results in decreased expression of NRG1 protein CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of NRG1 mRNA CTD PMID:34858468 arsane increases expression ISO RGD:731515 6480464 Arsenic results in increased expression of NRG1 mRNA CTD PMID:19945496 arsane affects methylation ISO RGD:731515 6480464 Arsenic affects the methylation of NRG1 gene CTD PMID:25304211 arsane decreases expression ISO RGD:735609 6480464 Arsenic results in decreased expression of NRG1 mRNA CTD PMID:24019935 arsane affects expression ISO RGD:731515 6480464 Arsenic affects the expression of NRG1 protein CTD PMID:24675094 arsenic atom increases expression ISO RGD:731515 6480464 Arsenic results in increased expression of NRG1 mRNA CTD PMID:19945496 arsenic atom affects methylation ISO RGD:731515 6480464 Arsenic affects the methylation of NRG1 gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:731515 6480464 Arsenic affects the expression of NRG1 protein CTD PMID:24675094 arsenic atom decreases expression ISO RGD:735609 6480464 Arsenic results in decreased expression of NRG1 mRNA CTD PMID:24019935 arsenite(3-) decreases expression ISO RGD:731515 6480464 arsenite results in decreased expression of NRG1 mRNA CTD PMID:23974009 arsenous acid increases expression ISO RGD:731515 6480464 Arsenic Trioxide results in increased expression of NRG1 mRNA CTD PMID:22521957 azoxystrobin decreases expression ISO RGD:731515 6480464 azoxystrobin results in decreased expression of NRG1 mRNA CTD PMID:33512557 benzo[a]pyrene decreases methylation ISO RGD:735609 6480464 Benzo(a)pyrene results in decreased methylation of NRG1 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:735609 6480464 Benzo(a)pyrene results in increased expression of NRG1 mRNA CTD PMID:32417428 benzo[a]pyrene decreases methylation ISO RGD:731515 6480464 Benzo(a)pyrene results in decreased methylation of NRG1 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:731515 6480464 Benzo(a)pyrene affects the methylation of NRG1 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:731515 6480464 Benzo(a)pyrene results in increased methylation of NRG1 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO RGD:731515 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:731515 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene increases methylation ISO RGD:731515 6480464 benzo(e)pyrene results in increased methylation of NRG1 intron CTD PMID:30157460 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NRG1 mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA, [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NRG1 mRNA more ... CTD PMID:25607892 , PMID:36041667 bisphenol A multiple interactions ISO RGD:731515 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of NRG1 gene CTD PMID:31601247 bisphenol A affects methylation ISO RGD:731515 6480464 bisphenol A affects the methylation of NRG1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:735609 6480464 bisphenol A results in increased expression of NRG1 mRNA CTD PMID:32353937 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NRG1 mRNA CTD PMID:34858468 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NRG1 gene CTD PMID:28505145 bisphenol A increases methylation ISO RGD:731515 6480464 bisphenol A results in increased methylation of NRG1 promoter CTD PMID:27271280 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NRG1 mRNA CTD PMID:25181051 more ... bisphenol F multiple interactions ISO RGD:731515 6480464 [bisphenol F co-treated with Fulvestrant] affects the methylation of NRG1 gene CTD PMID:31601247 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NRG1 mRNA CTD PMID:36041667 butan-1-ol multiple interactions ISO RGD:731515 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of NRG1 mRNA CTD PMID:29432896 butanal increases expression ISO RGD:731515 6480464 butyraldehyde results in increased expression of NRG1 mRNA CTD PMID:26079696 Butylparaben multiple interactions ISO RGD:731515 6480464 [butylparaben co-treated with NRG1 protein] promotes the reaction [ESR1 protein binds to MYC enhancer] more ... CTD PMID:26502914 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NRG1 mRNA CTD PMID:25607892 cadmium atom increases expression ISO RGD:731515 6480464 Cadmium results in increased expression of NRG1 mRNA CTD PMID:21120746 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of NRG1 mRNA CTD PMID:22110744 cadmium dichloride decreases expression ISO RGD:731515 6480464 Cadmium Chloride results in decreased expression of NRG1 mRNA CTD PMID:12160620 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of NRG1 promoter CTD PMID:22457795 cannabidiol increases expression ISO RGD:731515 6480464 Cannabidiol results in increased expression of NRG1 mRNA CTD PMID:36519830 carbofuran decreases expression EXP 6480464 Carbofuran results in decreased expression of NRG1 mRNA CTD PMID:28982980 carbon nanotube increases expression ISO RGD:735609 6480464 Nanotubes, Carbon results in increased expression of NRG1 mRNA CTD PMID:25554681 celecoxib multiple interactions ISO RGD:731515 6480464 Celecoxib inhibits the reaction [IL1B protein results in increased expression of and results in increased secretion of NRG1 protein] more ... CTD PMID:16357062 CGP 52608 multiple interactions ISO RGD:731515 6480464 CGP 52608 promotes the reaction [RORA protein binds to NRG1 gene] CTD PMID:28238834 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of NRG1 mRNA CTD PMID:34858468 choline multiple interactions ISO RGD:735609 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NRG1 mRNA CTD PMID:20938992 clozapine increases expression ISO RGD:731515 6480464 Clozapine results in increased expression of NRG1 mRNA CTD PMID:19502011 clozapine affects expression EXP 6480464 Clozapine affects the expression of NRG1 protein CTD PMID:18184445 clozapine affects response to substance ISO RGD:735609 6480464 NRG1 protein affects the susceptibility to Clozapine CTD PMID:15706234 cobalt dichloride decreases expression ISO RGD:731515 6480464 cobaltous chloride results in decreased expression of NRG1 mRNA CTD PMID:19320972 colforsin daropate hydrochloride multiple interactions ISO RGD:735609 6480464 [Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA, U 0126 inhibits the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA] CTD PMID:21047912 copper(II) sulfate increases expression ISO RGD:731515 6480464 Copper Sulfate results in increased expression of NRG1 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:731515 6480464 coumarin results in decreased phosphorylation of NRG1 protein CTD PMID:35688186 crocidolite asbestos affects expression ISO RGD:731515 6480464 Asbestos, Crocidolite affects the expression of NRG1 mRNA CTD PMID:24160326 crocidolite asbestos increases expression ISO RGD:735609 6480464 Asbestos, Crocidolite results in increased expression of NRG1 mRNA CTD PMID:29279043 cyclophosphamide increases expression ISO RGD:731515 6480464 Cyclophosphamide results in increased expression of NRG1 mRNA CTD PMID:21527772 cyclosporin A increases expression ISO RGD:731515 6480464 Cyclosporine results in increased expression of NRG1 mRNA CTD PMID:20106945 more ... D-glucose multiple interactions EXP 6480464 [NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose more ... CTD PMID:14711829 D-glucose increases transport EXP 6480464 NRG1 protein results in increased transport of Glucose CTD PMID:14711829 DDE multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA, [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of NRG1 mRNA CTD PMID:23640034 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of NRG1 mRNA CTD PMID:23914054 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of NRG1 mRNA, Dexamethasone results in increased expression of NRG1 protein CTD PMID:34189720 dexamethasone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of NRG1 protein] CTD PMID:34189720 diarsenic trioxide increases expression ISO RGD:731515 6480464 Arsenic Trioxide results in increased expression of NRG1 mRNA CTD PMID:22521957 dibutyl phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA, [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of NRG1 mRNA CTD PMID:15890375 dimethylarsinic acid increases expression ISO RGD:731515 6480464 Cacodylic Acid results in increased expression of NRG1 mRNA CTD PMID:17720352 dimethylarsinous acid decreases expression ISO RGD:731515 6480464 dimethylarsinous acid results in decreased expression of NRG1 mRNA CTD PMID:20886546 dioxygen multiple interactions ISO RGD:735609 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRG1 mRNA CTD PMID:30529165 diquat increases expression ISO RGD:735609 6480464 Diquat results in increased expression of NRG1 mRNA CTD PMID:36851058 disodium selenite multiple interactions ISO RGD:735609 6480464 [ptaquiloside co-treated with Sodium Selenite] results in increased expression of NRG1 mRNA CTD PMID:23274088 disodium selenite increases expression ISO RGD:735609 6480464 Sodium Selenite results in increased expression of NRG1 mRNA CTD PMID:23274088 diuron decreases expression EXP 6480464 Diuron results in decreased expression of NRG1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:731515 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:735609 6480464 NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of AKT1 protein] more ... CTD PMID:15833803 , PMID:19801490 doxorubicin decreases expression ISO RGD:731515 6480464 Doxorubicin results in decreased expression of NRG1 mRNA CTD PMID:29803840 doxorubicin decreases response to substance ISO RGD:731515 6480464 NRG1 protein results in decreased susceptibility to Doxorubicin CTD PMID:29305325 doxorubicin increases expression ISO RGD:731515 6480464 Doxorubicin results in increased expression of NRG1 mRNA CTD PMID:28940058 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of NRG1 protein alternative form CTD PMID:17308081 doxorubicin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP10 protein]] more ... CTD PMID:17005195 , PMID:19801490 doxorubicin affects response to substance ISO RGD:735609 6480464 NRG1 protein affects the susceptibility to Doxorubicin CTD PMID:19801490 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of NRG1 mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:731515 6480464 entinostat results in decreased expression of NRG1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:731515 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA CTD PMID:27188386 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA, [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NRG1 mRNA CTD PMID:25607892 epoxiconazole multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA, [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 etoposide increases expression ISO RGD:731515 6480464 Etoposide results in increased expression of NRG1 mRNA CTD PMID:29397400 fenamidone increases expression ISO RGD:735609 6480464 fenamidone results in increased expression of NRG1 mRNA CTD PMID:27029645 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of NRG1 mRNA CTD PMID:30307764 fluoranthene multiple interactions ISO RGD:735609 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of NRG1 mRNA CTD PMID:28329830 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of NRG1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:735609 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NRG1 mRNA CTD PMID:20938992 fonofos increases methylation ISO RGD:731515 6480464 Fonofos results in increased methylation of NRG1 promoter CTD PMID:22847954 fulvestrant multiple interactions ISO RGD:731515 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of NRG1 gene more ... CTD PMID:26502914 , PMID:31601247 fulvestrant increases methylation ISO RGD:731515 6480464 Fulvestrant results in increased methylation of NRG1 gene CTD PMID:31601247 furan increases expression ISO RGD:735609 6480464 furan results in increased expression of NRG1 mRNA CTD PMID:24183702 furan increases expression EXP 6480464 furan results in increased expression of NRG1 mRNA CTD PMID:25539665 , PMID:26194646 gemcitabine increases expression ISO RGD:731515 6480464 Gemcitabine results in increased expression of NRG1 mRNA CTD PMID:17039268 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NRG1 mRNA CTD PMID:33387578 glucose multiple interactions EXP 6480464 [NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose more ... CTD PMID:14711829 glucose increases transport EXP 6480464 NRG1 protein results in increased transport of Glucose CTD PMID:14711829 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of NRG1 protein CTD PMID:18184445 , PMID:26961615 Heliotrine increases expression EXP 6480464 heliotrine results in increased expression of NRG1 mRNA CTD PMID:32419051 hydrogen peroxide multiple interactions EXP 6480464 NRG1 protein alternative form inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] CTD PMID:17005195 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of NRG1 mRNA CTD PMID:21396975 ketamine decreases expression ISO RGD:735609 6480464 Ketamine results in decreased expression of NRG1 mRNA CTD PMID:20000043 L-methionine multiple interactions ISO RGD:735609 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NRG1 mRNA CTD PMID:20938992 linuron multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA, [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 lipopolysaccharide increases expression ISO RGD:731515 6480464 Lipopolysaccharides results in increased expression of NRG1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:731515 6480464 [S-(1 more ... CTD PMID:35811015 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP10 protein]] more ... CTD PMID:19801490 LY294002 multiple interactions ISO RGD:731515 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LHB protein results in decreased expression of NRG1 mRNA] CTD PMID:23071612 maneb multiple interactions ISO RGD:735609 6480464 [LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of NRG1 mRNA CTD PMID:23017109 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of NRG1 mRNA CTD PMID:28801915 methamphetamine affects response to substance ISO RGD:731515 6480464 NRG1 gene SNP affects the susceptibility to Methamphetamine CTD PMID:18316681 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of NRG1 mRNA CTD PMID:15890375 methapyrilene increases methylation ISO RGD:731515 6480464 Methapyrilene results in increased methylation of NRG1 intron CTD PMID:30157460 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of NRG1 mRNA CTD PMID:30047161 methotrexate increases expression ISO RGD:731515 6480464 Methotrexate results in increased expression of NRG1 mRNA CTD PMID:21678067 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of NRG1 gene CTD PMID:35440735 methyl methanesulfonate increases expression ISO RGD:731515 6480464 Methyl Methanesulfonate results in increased expression of NRG1 mRNA CTD PMID:21527772 methylmercury chloride decreases expression ISO RGD:731515 6480464 methylmercuric chloride results in decreased expression of NRG1 mRNA CTD PMID:28001369 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of NRG1 protein] CTD PMID:34189720 mono(2-ethylhexyl) phthalate increases expression ISO RGD:735609 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of NRG1 mRNA CTD PMID:22401849 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of NRG1 gene CTD PMID:33148267 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:735609 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [KU-32 compound inhibits the reaction [NRG1 protein results in increased expression of and results in increased phosphorylation of JUN protein]], benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [NRG1 protein results in increased expression of and results in increased phosphorylation of JUN protein] CTD PMID:23240583 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NRG1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NRG1 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:735609 6480464 Diethylnitrosamine results in increased expression of NRG1 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of NRG1 mRNA CTD PMID:14600272 , PMID:15890375 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of NRG1 mRNA CTD PMID:19716841 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions EXP 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [NRG1 protein results in increased transport of Glucose] CTD PMID:14711829 naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of NRG1 mRNA CTD PMID:24976557 nickel atom increases expression ISO RGD:731515 6480464 Nickel results in increased expression of NRG1 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression ISO RGD:731515 6480464 nickel chloride results in increased expression of NRG1 mRNA CTD PMID:17312168 nickel sulfate decreases expression ISO RGD:731515 6480464 nickel sulfate results in decreased expression of NRG1 mRNA CTD PMID:22714537 ochratoxin A decreases expression ISO RGD:731515 6480464 ochratoxin A results in decreased expression of NRG1 mRNA CTD PMID:22124623 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of NRG1 mRNA CTD PMID:23665939 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NRG1 mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of NRG1 mRNA CTD PMID:16716893 ozone multiple interactions ISO RGD:735609 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NRG1 mRNA CTD PMID:27106289 panobinostat multiple interactions ISO RGD:731515 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:731515 6480464 panobinostat results in decreased expression of NRG1 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:735609 6480464 Acetaminophen affects the expression of NRG1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NRG1 mRNA CTD PMID:33387578 paracetamol multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA CTD PMID:25607892 paraquat multiple interactions ISO RGD:735609 6480464 [LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of NRG1 mRNA CTD PMID:23017109 paraquat increases expression EXP 6480464 Paraquat results in increased expression of NRG1 mRNA CTD PMID:32680482 parathion increases methylation ISO RGD:731515 6480464 Parathion results in increased methylation of NRG1 promoter CTD PMID:22847954 PCB138 affects expression ISO RGD:731515 6480464 2 more ... CTD PMID:21703328 pentane-2,3-dione increases expression EXP 6480464 2, 3-pentanedione results in increased expression of NRG1 mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:735609 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NRG1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NRG1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of NRG1 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO RGD:731515 6480464 perfluorooctanoic acid results in decreased expression of NRG1 mRNA CTD PMID:25868421 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of NRG1 gene CTD PMID:33148267 phenobarbital affects expression ISO RGD:731515 6480464 Phenobarbital affects the expression of NRG1 mRNA CTD PMID:19159669 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of NRG1 mRNA, Phenylephrine results in decreased expression of NRG1 protein CTD PMID:16698793 phenylmercury acetate decreases expression ISO RGD:731515 6480464 Phenylmercuric Acetate results in decreased expression of NRG1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731515 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:735609 6480464 [Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA, U 0126 inhibits the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA] CTD PMID:21047912 picoxystrobin decreases expression ISO RGD:731515 6480464 picoxystrobin results in decreased expression of NRG1 mRNA CTD PMID:33512557 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of NRG1 mRNA CTD PMID:15890375 pirinixic acid decreases expression ISO RGD:735609 6480464 pirinixic acid results in decreased expression of NRG1 mRNA CTD PMID:17950772 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NRG1 mRNA CTD PMID:15890375 , PMID:19162173 pirinixic acid multiple interactions ISO RGD:735609 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of NRG1 mRNA] CTD PMID:17950772 potassium chromate multiple interactions ISO RGD:731515 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NRG1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:731515 6480464 potassium chromate(VI) results in decreased expression of NRG1 mRNA CTD PMID:22079256 potassium dichromate increases expression ISO RGD:735609 6480464 Potassium Dichromate results in increased expression of NRG1 mRNA CTD PMID:23608068 prochloraz multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA, [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 procymidone multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA, [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 progesterone multiple interactions ISO RGD:735609 6480464 NRG1 protein promotes the reaction [AREG protein results in increased abundance of Progesterone] CTD PMID:21047912 propanal increases expression ISO RGD:731515 6480464 propionaldehyde results in increased expression of NRG1 mRNA CTD PMID:26079696 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of NRG1 mRNA CTD PMID:30047161 propylparaben multiple interactions ISO RGD:731515 6480464 NRG1 protein promotes the reaction [propylparaben results in increased expression of MYC mRNA], propylparaben promotes the reaction [NRG1 protein results in increased expression of MYC mRNA] CTD PMID:26502914 prostaglandin E2 multiple interactions ISO RGD:731515 6480464 Dinoprostone inhibits the reaction [Celecoxib inhibits the reaction [IL1B protein results in increased expression of NRG1 mRNA]] CTD PMID:16357062 prostaglandin E2 increases expression ISO RGD:731515 6480464 Dinoprostone results in increased expression of NRG1 mRNA CTD PMID:16357062 Ptaquiloside multiple interactions ISO RGD:735609 6480464 [ptaquiloside co-treated with Sodium Selenite] results in increased expression of NRG1 mRNA CTD PMID:23274088 pyrimidifen decreases expression ISO RGD:731515 6480464 pyrimidifen results in decreased expression of NRG1 mRNA CTD PMID:33512557 raloxifene multiple interactions ISO RGD:731515 6480464 Raloxifene Hydrochloride inhibits the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] CTD PMID:26502914 resveratrol multiple interactions ISO RGD:731515 6480464 resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] more ... CTD PMID:17651959 resveratrol decreases expression ISO RGD:731515 6480464 resveratrol results in decreased expression of NRG1 mRNA CTD PMID:12002526 risperidone increases expression EXP 6480464 Risperidone results in increased expression of NRG1 protein CTD PMID:26961615 rotenone decreases expression ISO RGD:731515 6480464 Rotenone results in decreased expression of NRG1 mRNA CTD PMID:33512557 rotenone increases expression ISO RGD:731515 6480464 Rotenone results in increased expression of NRG1 mRNA CTD PMID:36586010 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:731515 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:731515 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine increases expression EXP 6480464 senecionine results in increased expression of NRG1 mRNA CTD PMID:32419051 serpentine asbestos affects expression ISO RGD:731515 6480464 Asbestos, Serpentine affects the expression of NRG1 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:731515 6480464 Silicon Dioxide analog results in increased expression of NRG1 mRNA, Silicon Dioxide results in increased expression of NRG1 mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenite affects methylation ISO RGD:731515 6480464 sodium arsenite affects the methylation of NRG1 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:731515 6480464 sodium arsenite results in increased expression of NRG1 mRNA, sodium arsenite results in increased expression of NRG1 protein CTD PMID:30137596 , PMID:36586010 sodium arsenite multiple interactions ISO RGD:731515 6480464 NRG1 protein promotes the reaction [sodium arsenite results in increased phosphorylation of ERBB2 protein] CTD PMID:30137596 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of NRG1 mRNA CTD PMID:22561333 , PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of NRG1 mRNA CTD PMID:19281266 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of NRG1 mRNA CTD PMID:30047161 sulforaphane increases expression ISO RGD:731515 6480464 sulforaphane results in increased expression of NRG1 mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:731515 6480464 Sunitinib results in increased expression of NRG1 mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO RGD:731515 6480464 Tamoxifen inhibits the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] CTD PMID:26502914 tebufenpyrad decreases expression ISO RGD:731515 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of NRG1 mRNA CTD PMID:33512557 temozolomide increases expression ISO RGD:731515 6480464 Temozolomide results in increased expression of NRG1 mRNA CTD PMID:31758290 tephrosin multiple interactions ISO RGD:731515 6480464 tephrosin inhibits the reaction [NRG1 protein affects the phosphorylation of AKT1 protein] more ... CTD PMID:20056314 terbufos increases methylation ISO RGD:731515 6480464 terbufos results in increased methylation of NRG1 promoter CTD PMID:22847954 tetrachloroethene increases expression ISO RGD:735609 6480464 Tetrachloroethylene results in increased expression of NRG1 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of NRG1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRG1 mRNA] CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NRG1 mRNA CTD PMID:23411599 , PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NRG1 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:735609 6480464 Trichloroethylene results in increased expression of NRG1 mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NRG1 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:731515 6480464 trichostatin A results in decreased expression of NRG1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:731515 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA CTD PMID:27188386 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of NRG1 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:735609 6480464 triptonide results in increased expression of NRG1 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:731515 6480464 troglitazone results in increased expression of NRG1 mRNA CTD PMID:19140230 valproic acid increases methylation ISO RGD:731515 6480464 Valproic Acid results in increased methylation of NRG1 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:731515 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:731515 6480464 Valproic Acid results in decreased expression of NRG1 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:731515 6480464 Valproic Acid results in increased expression of NRG1 mRNA CTD PMID:19101580 , PMID:23179753 vinclozolin multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA, [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 vorinostat multiple interactions ISO RGD:731515 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:731515 6480464 vorinostat results in decreased expression of NRG1 mRNA CTD PMID:26272509 zinc sulfate multiple interactions EXP 6480464 Zinc Sulfate affects the expression of and affects the splicing of NRG1 mRNA CTD PMID:10878590 zoledronic acid decreases expression ISO RGD:731515 6480464 zoledronic acid results in decreased expression of NRG1 mRNA CTD PMID:24714768
